- Home
- ONC vs STE Comparison
ONC vs STE Comparison
Compare ONC & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- STE
- Stock Information
- Founded
- ONC 2010
- STE 1985
- Country
- ONC Cayman Islands
- STE United States
- Employees
- ONC N/A
- STE N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- STE Industrial Specialties
- Sector
- ONC Health Care
- STE Health Care
- Exchange
- ONC Nasdaq
- STE Nasdaq
- Market Cap
- ONC 19.3B
- STE 22.1B
- IPO Year
- ONC N/A
- STE 1992
- Fundamental
- Price
- ONC $255.37
- STE $220.55
- Analyst Decision
- ONC
- STE Buy
- Analyst Count
- ONC 0
- STE 6
- Target Price
- ONC N/A
- STE $260.00
- AVG Volume (30 Days)
- ONC 357.2K
- STE 472.2K
- Earning Date
- ONC 02-27-2025
- STE 02-05-2025
- Dividend Yield
- ONC N/A
- STE 1.04%
- EPS Growth
- ONC N/A
- STE N/A
- EPS
- ONC N/A
- STE 4.72
- Revenue
- ONC $3,351,304,621.00
- STE $5,398,371,000.00
- Revenue This Year
- ONC $992.37
- STE $7.26
- Revenue Next Year
- ONC $24.68
- STE $6.20
- P/E Ratio
- ONC N/A
- STE $46.51
- Revenue Growth
- ONC 50.22
- STE 15.29
- 52 Week Low
- ONC $126.97
- STE $197.82
- 52 Week High
- ONC $260.98
- STE $248.24
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- STE 54.88
- Support Level
- ONC N/A
- STE $214.81
- Resistance Level
- ONC N/A
- STE $222.28
- Average True Range (ATR)
- ONC 0.00
- STE 4.18
- MACD
- ONC 0.00
- STE -0.46
- Stochastic Oscillator
- ONC 0.00
- STE 48.10
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.